LDL Cholesterol Reduction Following Ezetimibe Initiation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT07839741
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT07839741
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Portugal
- Registry status
- Recruiting
Technical summary
Registry record NCT07839741. Allocation not applicable; no masking; primary purpose treatment. Start 2025-06-01 (actual); primary completion 2027-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- LDL Cholesterol Reduction Following Ezetimibe Initiation
- Acronym
- EZE-TRACK
- Condition
- Atherosclerotic Cardiovascular Disease (ASCVD)
- Condition
- Cardiovascular Risk
- Condition
- LDL Cholesterol
- Intervention (Drug)
- Ezetimibe
- Lead sponsor
- Universidade do Porto
Record details
- Record id
cardio:ct-nct07839741- Content hash
f7e2051c4e539d7635e5c8925dc880fd39c54d3f1c4128ecdfa8a3d5280e739e